EtiraRx is a biopharmaceutical research firm that offers treatment for therapy-resistant metastatic breast cancer.
EtiraRx has raised $2.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in May 2026.
EtiraRx is headquartered in Dallas, United States.
EtiraRx is a biopharmaceutical research firm that offers treatment for therapy-resistant metastatic breast cancer.
EtiraRx is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"EtiraRx — Funding & Investors." VCBacked, May 13, 2026, https://www.vcbacked.co/company/etirarx. Accessed August 15, 2026.
VCBacked. (2026). EtiraRx — Funding & Investors. Retrieved August 15, 2026, from https://www.vcbacked.co/company/etirarx
{{cite web |title=EtiraRx — Funding & Investors |url=https://www.vcbacked.co/company/etirarx |website=VCBacked |access-date=August 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated